看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 8.1x - 8.9x | 8.5x |
| Selected Fwd EBITDA Multiple | 4.6x - 5.0x | 4.8x |
| Fair Value | €0.57 - €0.67 | €0.62 |
| Upside | 49.6% - 76.0% | 62.8% |
| Benchmarks | Ticker | Full Ticker |
| EssilorLuxottica Société anonyme | 0OMK | LSE:0OMK |
| Surgical Innovations Group plc | SUN | AIM:SUN |
| MyHealthChecked PLC | MHC | AIM:MHC |
| Creo Medical Group PLC | CREO | AIM:CREO |
| Abingdon Health Plc | ABDX | AIM:ABDX |
| INSPECS Group plc | 4GV | DB:4GV |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| 0OMK | SUN | MHC | CREO | ABDX | 4GV | ||
| LSE:0OMK | AIM:SUN | AIM:MHC | AIM:CREO | AIM:ABDX | DB:4GV | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 9.2% | NM- | NM- | NM- | NM- | 8.2% | |
| 3Y CAGR | 12.3% | NM- | NM- | NM- | NM- | -4.3% | |
| Latest Twelve Months | 7.5% | -1189.4% | -192.8% | 10.3% | -3.8% | 3.3% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 19.4% | -7.5% | -2276.8% | -29977.1% | -108.4% | 5.8% | |
| Prior Fiscal Year | 20.4% | 2.1% | 8.3% | -104.8% | -73.7% | 5.4% | |
| Latest Fiscal Year | 21.0% | -2.9% | -1.9% | -72.1% | -20.4% | 5.8% | |
| Latest Twelve Months | 21.0% | -4.1% | -11.8% | -74.9% | -29.8% | 5.8% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 4.70x | 0.46x | 0.13x | 1.37x | 2.78x | 0.40x | |
| EV / LTM EBITDA | 22.4x | -11.4x | -1.1x | -1.8x | -9.3x | 6.9x | |
| EV / LTM EBIT | 35.8x | -8.2x | -1.0x | -1.6x | -8.0x | 23.2x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -11.4x | -1.8x | 22.4x | ||||
| Historical EV / LTM EBITDA | 6.7x | 12.1x | 237.3x | ||||
| Selected EV / LTM EBITDA | 8.1x | 8.5x | 8.9x | ||||
| (x) LTM EBITDA | 11 | 11 | 11 | ||||
| (=) Implied Enterprise Value | 92 | 97 | 102 | ||||
| (-) Non-shareholder Claims * | (38) | (38) | (38) | ||||
| (=) Equity Value | 54 | 59 | 63 | ||||
| (/) Shares Outstanding | 115.3 | 115.3 | 115.3 | ||||
| Implied Value Range | 0.47 | 0.51 | 0.55 | ||||
| FX Rate: GBP/EUR | 0.9 | 0.9 | 0.9 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.54 | 0.59 | 0.64 | 0.38 | |||
| Upside / (Downside) | 42.2% | 55.0% | 67.8% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 0OMK | SUN | MHC | CREO | ABDX | 4GV | |
| Enterprise Value | 124,015 | 6 | 1 | 42 | 19 | 76 | |
| (+) Cash & Short Term Investments | 2,251 | 0 | 6 | 10 | 4 | 24 | |
| (+) Investments & Other | 823 | 0 | 0 | 2 | 0 | 0 | |
| (-) Debt | (13,216) | (1) | (0) | (14) | (1) | (62) | |
| (-) Other Liabilities | (626) | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 113,247 | 5 | 7 | 39 | 22 | 38 | |
| (/) Shares Outstanding | 456.7 | 932.8 | 52.0 | 402.5 | 375.9 | 115.3 | |
| Implied Stock Price | 247.96 | 0.01 | 0.14 | 0.10 | 0.06 | 0.33 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.86 | |
| Implied Stock Price (Trading Cur) | 247.96 | 0.01 | 0.14 | 0.10 | 0.06 | 0.38 | |
| Trading Currency | EUR | GBP | GBP | GBP | GBP | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.86 | |